BLI is a pioneering biomedical company at the forefront of deep tech innovation. The focus lies in the development of cutting-edge scaffolds for tissue regeneration, with plans to address various areas such as post-breast mastectomy tissue regeneration, diabetic foot care, and more.

The company operates two distinct business segments: scaffold production and sales, alongside the tissue regeneration business, which is currently in the product development phase.